Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB050465 in relapsed or refractory mantle cell lymphoma
2017-003148-19Phase 2Completed
- Sponsor
- Incyte
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of parsaclisib in mantle cell lymphoma (MCL) (2 cohorts), sponsored by Incyte. Primary endpoint: Objective response rate. Started Dec 2017; status: completed.
02
Drugs
parsaclisib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2017-003148-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003148-19.